申请人:TERUMO KABUSHIKI KAISHA
公开号:EP0397859A1
公开(公告)日:1990-11-22
Pyrazine derivatives represented by general formula (I), wherein X represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group or a cyano group, R1 represents a hydrogen atom, a lower alkyl group or a group of (a) (wherein X is as defined above), R2 represents a hydrogen atom, a halogen atom or (a) (wherein X is as defined above), R3 represents a hydrogen atom, a halogen atom, a lower alkyl group, a cyano group, a naphthylmethyl group, a benzyl group or (b) (wherein R4represents a hydrogen atom, a halogen atom or a lower alkylamino group), a carboxyl group or a lower alkoxycarbonyl group or, when taken together, R2 and R3 represent a cyclohexane ring or a benzene ring together with the carbon atoms to which they are bound, provided that the case where X represents a hydrogen atom, R, represents (a) (wherein X represents a hydrogen atom), and R2 and R3 represent hydrogen atoms and the case where X represents a hydrogen atom, R1 represents a hydrogen atom, R2 represents (a) (wherein X represents a hydrogen atom), and R3 represents a methyl group are excluded. The pyrazine derivatives have a strong blood platelet agglutination depressing effect and a cyclooxygenase inhibiting effect. The above-described compounds are used as blood platelet agglutination inhibitor or anti-inflammatory agents.
通式(I)代表的吡嗪衍生物,其中X代表氢原子、卤素原子、低级烷基、低级烷氧基或氰基,R1代表氢原子、低级烷基或(a)基团(其中X如上定义),R2代表氢原子、卤素原子或(a)基团(其中X如上定义),R3代表氢原子、卤素原子、低级烷基、氰基、腈基、R3 代表氢原子、卤素原子、低级烷基、氰基、萘甲基、苄基或 (b) 基团(其中 R4 代表氢原子、卤素原子或低级烷基氨基)、羧基或低级烷氧羰基,或者当 R2 和 R3 结合在一起时,R2 和 R3 与它们所结合的碳原子一起代表环己烷环或苯环,但不包括 X 代表氢原子、R 代表(a)(其中 X 代表氢原子)、R2 和 R3 代表氢原子的情况,以及 X 代表氢原子、R1 代表氢原子、R2 代表(a)(其中 X 代表氢原子)、R3 代表甲基的情况。吡嗪衍生物具有很强的血小板凝集抑制作用和环氧化酶抑制作用。上述化合物可用作血小板凝集抑制剂或抗炎剂。